Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Standard AOD-9604 Dosing Protocol Subcutaneous Injection Dosing: Beginner: 250 mcg per dose, once daily Intermediate: 300-400 mcg per dose, once daily or divided into two doses Advanced: 500 mcg per dose, once daily or 250 mcg twice daily Oral Administration Dosing (if using oral formulation): Standard: 1-2 mg per dose, once daily on empty stomach Higher protocols: Up to 5-10 mg daily, as studied in clinical trials Frequency: Once daily (morning preferred) or twice daily (morning and early afternoon) Timing: Best administered on an empty stomach, typically upon waking or before exercise Cycle Length: 12-16 weeks for initial assessment, with potential for longer protocols based on response Off Cycle: 4-8 weeks between cycles, though not strictly required based on current research Note: Start at the lower end of the dosing range to assess individual tolerance
A research-grade source publishes a per-batch COA, names a purity figure, and labels the product for research use only
Shipping for temperature-sensitive peptides requires cold chain logistics
Hyperbaric oxygen directly increases oxygen availability to wounds while BPC-157 works through angiogenesis and cellular signaling
In the context of the present invention, a base is considered as a substance capable of forming a cation in a solution, particularly in an aqueous and aqueous/alcoholic solution
Growth factor expression: Beyond VEGF, BPC-157 influences epidermal growth factor (EGF), fibroblast growth factor (FGF), and various cytokines involved in tissue repair
US$ 22.14
US$ 28.43
US$ 25.61
US$ 27.85
US$ 22.65
US$ 27.30